Home › NDC Lookup › RxCUI directory › RxCUI 311354

Lisinopril 5 MG Oral Tablet — RxCUI 311354

RxNorm drug concept · Semantic clinical drug
RxCUI 311354 Semantic clinical drug · SCD ● Current RxNorm concept 155 FDA products 434 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311354
Official nameLisinopril 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped155
Package NDCs mapped434
Reported Medicaid activity (SDUD)6,779,269 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lisinopril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lisinopril is mainly prescribed to treat high blood pressure — it relaxes your blood vessels so your heart doesn't have to work as hard. It's also used to help manage heart failure...
  • Good news — food doesn't affect how lisinopril works, so you can take it with or without a meal. What matters most is taking it at roughly the same time each day. Once a day is the...
  • Can I take lisinopril with food, or does it have to be on an empty stomach?
  • Yes, that cough is one of the most well-known side effects of ACE inhibitors like lisinopril. It happens because the medicine also affects a chemical in the lungs called bradykinin...
📖 Read our full Lisinopril guide →

🕸️ Concept Web — How Lisinopril 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lisinopril 5 MG Oral Tablet RxCUI 311354

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lisinopril 29046
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zestril 196472
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lisinopril Oral Tablet 372614
    • Lisinopril Oral Product 1164689
    • Lisinopril Pill 1164690
    • Lisinopril Oral Tablet [Zestril] 368248
    • Zestril Oral Product 1187283
    • Zestril Pill 1187284
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lisinopril 5 MG SCDC · 316156
  • Lisinopril Oral Tablet SCDF · 372614
  • Lisinopril Oral Product SCDG · 1164689
  • Lisinopril Pill SCDG · 1164690

Brand-Name Concepts

  • Lisinopril 5 MG Oral Tablet [Zestril] SBD · 104376
  • Lisinopril 5 MG [Zestril] SBDC · 563610
  • Lisinopril Oral Tablet [Zestril] SBDF · 368248
  • Zestril Oral Product SBDG · 1187283
  • Zestril Pill SBDG · 1187284
  • Zestril BN · 196472

📦 FDA Products & Package NDCs

155 products · 434 package NDCs
434 package NDCs map to RxCUI 311354 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76420-0340-60 60 TABLET in 1 BOTTLE (76420-340-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0340-90 90 TABLET in 1 BOTTLE (76420-340-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0341-00 1000 TABLET in 1 BOTTLE (76420-341-00) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0341-01 100 TABLET in 1 BOTTLE (76420-341-01) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0341-30 30 TABLET in 1 BOTTLE (76420-341-30) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0341-60 60 TABLET in 1 BOTTLE (76420-341-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0341-90 90 TABLET in 1 BOTTLE (76420-341-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0342-00 1000 TABLET in 1 BOTTLE (76420-342-00) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0342-01 100 TABLET in 1 BOTTLE (76420-342-01) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0342-30 30 TABLET in 1 BOTTLE (76420-342-30) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0342-60 60 TABLET in 1 BOTTLE (76420-342-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0342-90 90 TABLET in 1 BOTTLE (76420-342-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0343-00 1000 TABLET in 1 BOTTLE (76420-343-00) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0343-01 100 TABLET in 1 BOTTLE (76420-343-01) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0343-30 30 TABLET in 1 BOTTLE (76420-343-30) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0343-60 60 TABLET in 1 BOTTLE (76420-343-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0343-90 90 TABLET in 1 BOTTLE (76420-343-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-00 1000 TABLET in 1 BOTTLE (76420-344-00) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-01 100 TABLET in 1 BOTTLE (76420-344-01) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-05 500 TABLET in 1 BOTTLE (76420-344-05) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-30 30 TABLET in 1 BOTTLE (76420-344-30) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-60 60 TABLET in 1 BOTTLE (76420-344-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0344-90 90 TABLET in 1 BOTTLE (76420-344-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0345-00 1000 TABLET in 1 BOTTLE (76420-345-00) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0345-01 100 TABLET in 1 BOTTLE (76420-345-01) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0345-30 30 TABLET in 1 BOTTLE (76420-345-30) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0345-60 60 TABLET in 1 BOTTLE (76420-345-60) LISINOPRIL Asclemed USA, Inc. 2025-05-02
76420-0345-90 90 TABLET in 1 BOTTLE (76420-345-90) LISINOPRIL Asclemed USA, Inc. 2025-05-02
82009-0062-05 500 TABLET in 1 BOTTLE (82009-062-05) Lisinopril Quallent Pharmaceuticals Health LLC 2023-07-07
82009-0063-10 1000 TABLET in 1 BOTTLE (82009-063-10) Lisinopril Quallent Pharmaceuticals Health LLC 2023-07-07
82009-0064-10 1000 TABLET in 1 BOTTLE (82009-064-10) Lisinopril Quallent Pharmaceuticals Health LLC 2023-07-07
82009-0065-10 1000 TABLET in 1 BOTTLE (82009-065-10) Lisinopril Quallent Pharmaceuticals Health LLC 2023-07-07
82009-0066-10 1000 TABLET in 1 BOTTLE (82009-066-10) Lisinopril Quallent Pharmaceuticals Health LLC 2023-07-07
87441-0049-01 30 TABLET in 1 BLISTER PACK (87441-049-01) Lisinopril Unit Dose Solutions, Inc. 2026-06-25
Observed labelers: Solco healthcare U.S., LLC (47) · Exelan Pharmaceuticals Inc. (44) · Exelan Pharmaceuticals, Inc (44) · Asclemed USA, Inc. (31) · Aurobindo Pharma Limited (30) · PD-Rx Pharmaceuticals, Inc. (28) · +26 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.